Operations
The company's first two partners to leverage OMNY's dataset are life sciences company ArisGlobal and clinical trial design company QuantHealth.
The company will use the funds to scale its growth within healthcare systems and expand its AI innovation.
Dr. Yusuf Sherwani, CEO and cofounder of Pelago, describes how the company partners with employers and health plans to control the costs of substance misuse disorders and the effectiveness of the virtual evidence-based treatment platform.
HIMSS24
US Health and Human Services CISO La Monte Yarborough discusses the HHS 405(d) program, which provides free educational resources and cybersecurity best practices in English and Spanish for healthcare organizations of all sizes.
Rad AI's genAI tools will be offered through Bayer's vendor-neutral Calantic Digital Solution marketplace, which provides AI-enabled clinical and operational applications.
Rich Miller, chief innovation officer at QGenda, says that health systems need to address burnout, staffing and employee issues in a less fragmented way.
HIMSS24
Dr. Jeffrey Chen, clinical advisor at No Barrier AI, believes the company's AI medical interpreter app could improve outcomes for low-English-proficiency patients, prevent clinician burnout and reduce operational costs.
HIMSS24
Eric Robertson, chief technology strategist and growth officer at Jeeva Care, talks about how the company's AI companion helps patients track health goals and stick to their care program after a hospital stay.
HIMSS24
Patient advocate Dave deBronkart believes interoperability advances could soon enable everyone to carry International Patient Summary QR codes with their own health data that could be scanned into EHRs in case of emergency.
The company will use the funds to expand its employer-focused offerings into Florida.